84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000025936 | 2017/06/12 | 20/02/2017 | Japanese AntibaCterial drug maNagemEnt for cardiac Sarcoidosis Trial | Japanese AntibaCterial drug maNagemEnt for cardiac Sarcoidosis Trial - J-ACNES | Cardiac sarcoidosis | combination therapy group: Prednisolone; Predonisolone start from 30mg/day and continue same dose for one month. After one month, prednisolone decrease 25mg, 20mg, 15mg, 10mg every 2-4 weeks. Finally, maintenance dose of predonisolone is 7.5mg. Antimicrobial agent; Clarithromycin start from 400mg/day for 24weeks. Doxycycline start 100mg/day for 22 weeks after 2 months of clarithromycin therapy. Prednisolone; Predonisolone start from 30mg/day and continue same dose for one month. After one month, prednisolone decrease 25mg, 20mg, 15mg, 10mg every 2-4 weeks. Finally, maintenance dose of predonisolone is 7.5mg. | National cerebral and cardiovascular center | NULL | Complete: follow-up continuing | 20years-old | Not applicable | Male and Female | 80 | Not selected | Japan |
| 2 | JPRN-jRCTs031180301 | 01/05/2017 | 15/03/2019 | Antibacterial therapy for severe sarcoid uveitis | Study of antibacterial therapy for severe uveitis by sarcoidosis | Severe uveitis by sarcoidosis Other eyes and adnexal disease | Ordinary steroid medication with Clarithromycin and minomycin | Takase Hiroshi | NULL | Complete | 20age | 80age | Both | 10 | Phase 1-2 | Japan |